Lin Yuan Ching Matthew Md is categorized under Orthopedic Doctors and Physicians in Arcadia, CA and active since 2001.
Lin Yuan Ching Matthew Md was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Matthew Y C Lin at the company’s single location by writing to 622 West Duarte Road # 302, Arcadia, California CA 91007 or by phoning (650) 327-5228. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Lin Yuan Ching Matthew Md |
Contact Person: | Matthew Y C Lin |
Address: | 622 West Duarte Road # 302, Arcadia, California 91007 |
Phone Number: | (650) 327-5228 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Lin Yuan Ching Matthew Md was started in 2001 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Matthew Y C Lin for inquiries that concern Lin Yuan Ching Matthew Md by calling the company number (650) 327-5228, as your correspondence is most welcome. Additionally, the physical location of the single location of Lin Yuan Ching Matthew Md can be found at the coordinates as well as the street address 622 West Duarte Road # 302 in Arcadia, California 91007.
For its online presence, you may visit Lin Yuan Ching Matthew Md’s website at and engage with its social media outlets through on Twitter and on Facebook.